<i>SDHB</i> mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paragangliomaJulien Hadoux, Éric Baudin, Judith Favier et al.|International Journal of Cancer|2014Cited by 207
One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and ParagangliomaS. Hescot, Claire Bournaud-Salinas, Christelle de la Fouchardière et al.|The Journal of Clinical Endocrinology & Metabolism|2013Cited by 119
Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one yearS. Hescot, Éric Baudin, Sophie Leboulleux et al.|15th International & 14th European Congress of Endocrinology|2012Cited by 0